Does RANIBIZUMAB Cause Transient ischaemic attack? 142 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Transient ischaemic attack have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.9% of all adverse event reports for RANIBIZUMAB.
142
Reports of Transient ischaemic attack with RANIBIZUMAB
0.9%
of all RANIBIZUMAB reports
6
Deaths
77
Hospitalizations
How Dangerous Is Transient ischaemic attack From RANIBIZUMAB?
Of the 142 reports, 6 (4.2%) resulted in death, 77 (54.2%) required hospitalization, and 7 (4.9%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which RANIBIZUMAB Alternatives Have Lower Transient ischaemic attack Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE